Quantitation of Translocator Protein Binding in Human Brain with the Novel Radioligand [18F]-FEPPA and Positron Emission Tomography

This article describes the kinetic modeling of [18F]-FEPPA binding to translocator protein 18 kDa in the human brain using high-resolution research tomograph (HRRT) positron emission tomography. Positron emission tomography scans were performed in 12 healthy volunteers for 180 minutes. A two-tissue compartment model (2-CM) provided, with no exception, better fits to the data than a one-tissue model. Estimates of total distribution volume (VT), specific distribution volume (VS), and binding potential (BPND) demonstrated very good identifiability (based on coefficient of variation (COV)) for all the regions of interest (ROIs) in the gray matter (COV VT < 7%, COV VS < 8%, COV BPND < 11%). Reduction of the length of the scan to 2 hours is feasible as VS and VT showed only a small bias (6% and 7.5%, respectively). Monte Carlo simulations showed that, even under conditions of a 500% increase in specific binding, the identifiability of VT and VS was still very good with COV<10%, across high-uptake ROIs. The excellent identifiability of VT values obtained from an unconstrained 2-CM with data from a 2-hour scan support the use of VT as an appropriate and feasible outcome measure for [18F]-FEPPA.

[1]  S. Snyder,et al.  Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Alan A. Wilson,et al.  Comparison of [11C]PBR28 and [18F]FEPPA as CNS peripheral benzodiazepine receptor PET ligands in the pig , 2008 .

[3]  E. Meyer Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H215O autoradiographic method and dynamic PET. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  M E Phelps,et al.  Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  Masanori Ichise,et al.  Correlation between FEPPA uptake and microglia activation in 6-OHDA injured rat brain , 2010, NeuroImage.

[6]  L. Mchenry Cerebral blood flow. , 1966, The New England journal of medicine.

[7]  P. Ferrara,et al.  A 3D model of the peripheral benzodiazepine receptor and its implication in intra mitochondrial cholesterol transport. , 1993, Journal of molecular graphics.

[8]  Ming-Kai Chen,et al.  Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. , 2008, Pharmacology & therapeutics.

[9]  Roger N. Gunn,et al.  Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.

[10]  Design, synthesis, and structure-activity relationships of novel tetracyclic compounds as peripheral benzodiazepine receptor ligands. , 2004, Bioorganic & medicinal chemistry.

[11]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[12]  Richard S. J. Frackowiak,et al.  Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. , 1990, Brain : a journal of neurology.

[13]  D L Alexoff,et al.  A Strategy for Removing the Bias in the Graphical Analysis Method , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  Philippe Hantraye,et al.  11C-DPA-713: A Novel Peripheral Benzodiazepine Receptor PET Ligand for In Vivo Imaging of Neuroinflammation , 2007, Journal of Nuclear Medicine.

[15]  D. Wong,et al.  Column-switching HPLC for the analysis of plasma in PET imaging studies. , 2000, Nuclear medicine and biology.

[16]  Ronald Boellaard,et al.  Optimization algorithms and weighting factors for analysis of dynamic PET studies , 2006, Physics in medicine and biology.

[17]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[18]  Robert B. Innis,et al.  Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation , 2008, NeuroImage.

[19]  M. James,et al.  Development of ligands for the peripheral benzodiazepine receptor. , 2006, Current medicinal chemistry.

[20]  Roger N Gunn,et al.  Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of Neuroinflammation , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  Robert B. Innis,et al.  Strategies to Improve Neuroreceptor Parameter Estimation by Linear Regression Analysis , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[22]  C Crouzel,et al.  PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  C. Braestrup,et al.  High densities of benzodiazepine receptors in human cortical areas , 1977, Nature.

[24]  C Crouzel,et al.  Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. , 1986, Circulation.

[25]  Robert B. Innis,et al.  Mixed-Affinity Binding in Humans with 18-kDa Translocator Protein Ligands , 2011, The Journal of Nuclear Medicine.

[26]  Shitij Kapur,et al.  An automated method for the extraction of regional data from PET images , 2006, Psychiatry Research: Neuroimaging.

[27]  R. Carson,et al.  Consensus nomenclature: its time has come , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  V. Papadopoulos,et al.  Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis , 1997, Steroids.

[29]  H. Akaike A new look at the statistical model identification , 1974 .

[30]  Colin Studholme,et al.  An overlap invariant entropy measure of 3D medical image alignment , 1999, Pattern Recognit..

[31]  R Tomczak,et al.  In vivo imaging of activated microglia using [11 C]PK11195 and positron emission tomography in patients after ischemic stroke , 2000, Neuroreport.

[32]  Yota Fujimura,et al.  Quantification of Translocator Protein (18 kDa) in the Human Brain with PET and a Novel Radioligand, 18F-PBR06 , 2009, Journal of Nuclear Medicine.

[33]  Zsolt Szabo,et al.  Modified Regression Model for the Logan Plot , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  J Versijpt,et al.  PET visualization of microglia in multiple sclerosis patients using [11C]PK11195 , 2003, European journal of neurology.

[35]  C Burger,et al.  Requirements and implementation of a flexible kinetic modeling tool. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[36]  André Syrota,et al.  Synthesis of N‐(11C) methyl, N‐(methyl‐1 propyl), (chloro‐2 phenyl)‐1 isoquinoleine carboxamide‐3 (PK 11195): A new ligand for peripheral benzodiazepine receptors , 1984 .

[37]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[38]  I. Kanno,et al.  Error Analysis of a Quantitative Cerebral Blood Flow Measurement Using H215O Autoradiography and Positron Emission Tomography, with Respect to the Dispersion of the Input Function , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[39]  G. Kreutzberg,et al.  Microglia: Intrinsic immuneffector cell of the brain , 1995, Brain Research Reviews.

[40]  V. Papadopoulos,et al.  In vitro studies on the role of the peripheral-type benzodiazepine receptor in steroidogenesis , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[41]  R B Banati,et al.  In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. , 2001, Brain : a journal of neurology.

[42]  Ryuji Nakao,et al.  Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[43]  Sylvain Houle,et al.  Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors. , 2008, Nuclear medicine and biology.

[44]  A. Basbaum,et al.  Labelling of peripheral-type benzodiazepine binding sites in human brain with [3H]PK 11195: Anatomical and subcellular distribution , 1987, Brain Research Bulletin.

[45]  Badreddine Bencherif,et al.  Application of MRI-based partial-volume correction to the analysis of PET images of mu-opioid receptors using statistical parametric mapping. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.